Oruka Therapeutics Insider Sells $6.2 Million Worth of Shares
Carl Dambkowski, Director at Oruka Therapeutics (ORKA), sold 105,000 shares worth approximately $6.2 million on May 21, 2026, reducing his direct equity stake by nearly 58%. The transaction followed the exercise of vested options and was reported via an SEC Form 4 filing.
Tickers: $ORKA
Topics: biotech executive activity stock sale